Search Results 461-470 of 6943 for 搜索引擎记录咨询邮箱：lgooxc@hotmail.com

  1. Factors Assessed - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    The eMERGE Genome Informed Risk Assessment study at Mayo Clinic outlines risk factors for nine common conditions for adult participants and four common ...

  2. Pulmonary Hypertension Association Registry - Mayo Clinic

    About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.

  3. Medical Students at Mayo Clinic in Florida Are The First to Celebrate Graduation This May - News Archive

    Email. Nine medical students in Florida celebrated their graduation from Mayo Clinic Alix School of Medicine on Saturday, May 13. They now will move on to ...

  4. Contact - Biospecimen Accessioning and Processing Core - Mayo Clinic Research

    Gouri Mahajan, M.B.B.S., Ph.D. Medical Director, Arizona Biorepository; Email: mahajan.gouri@mayo.edu. Florida. Andras Khoor, M.D., Ph ...

  5. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...

  6. Contact - Survival analysis - Mayo Clinic Research

    Elizabeth (Beth) J. Atkinson, M.S.. Survival Analysis; Mayo Clinic Harwick Building, 8th Floor 200 First St. SW Rochester, MN 55905; Email: atkinson@mayo.

  7. A Study to Evaluate the Effectiveness, Safety and Tolerability of PF-06823859 In Adults With Moderate-to-Severe Dermatomyositis - Mayo Clinic

    Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions ...

  8. Cervical Cancer Screening Barriers - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors - Mayo Clinic

    Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions ...

  10. Prevalence of Barrett’s Esophagitis in Erosive Esophagitis - Mayo Clinic

    The purpose of this study is to learn more about the prevalence of gastroesophageal reflux among patients with esophagitis using long term proton-pump-inhibitor ...